POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial

Bibliographic Details
Main Authors: R. Agarwal, A. Joseph, P. Rossing, B. Pitt, S. Anker D, G. Filippatos, L. Ruilope M, P. Kolkhof, C. Scott, R. Lawatscheck, G. Bakris L
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921010135
_version_ 1828888088123801600
author R. Agarwal
A. Joseph
P. Rossing
B. Pitt
S. Anker D
G. Filippatos
L. Ruilope M
P. Kolkhof
C. Scott
R. Lawatscheck
G. Bakris L
author_facet R. Agarwal
A. Joseph
P. Rossing
B. Pitt
S. Anker D
G. Filippatos
L. Ruilope M
P. Kolkhof
C. Scott
R. Lawatscheck
G. Bakris L
author_sort R. Agarwal
collection DOAJ
first_indexed 2024-12-13T12:16:23Z
format Article
id doaj.art-f5f015bffd0149eab8877edcb588884f
institution Directory Open Access Journal
issn 2468-0249
language English
last_indexed 2024-12-13T12:16:23Z
publishDate 2021-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj.art-f5f015bffd0149eab8877edcb588884f2022-12-21T23:46:42ZengElsevierKidney International Reports2468-02492021-04-0164S360S361POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trialR. Agarwal0A. Joseph1P. Rossing2B. Pitt3S. Anker D4G. Filippatos5L. Ruilope M6P. Kolkhof7C. Scott8R. Lawatscheck9G. Bakris L10Richard L. Roudebush VA Medical Center and Indiana University, School of Medicine, Indianapolis, United KingdomBayer AG, Cardiology and Nephrology Clinical Development, Berlin, GermanySteno Diabetes Center Copenhagen and University of Copenhagen, Department of Clinical Medicine, Copenhagen, DenmarkUniversity of Michigan School of Medicine, Department of Medicine, Ann Arbor, United StatesBerlin Institute of Health Center for Regenerative Therapies- German Centre for Cardiovascular Research Partner Site Berlin- Charité Universitätsmedizin, Department of Cardiology CVK, Berlin, GermanyNational and Kapodistrian University of Athens- School of Medicine- Attikon University Hospital, Department of Cardiology, Athens, GreeceInstitute of Research imas12 & CIBER-CV- Hospital Universitario 12 de Octubre and European University of Madrid, Cardiorenal Translational Laboratory and Hypertension Unit & Faculty of Sport Sciences, Madrid, SpainBayer AG, Research and Development- Preclinical Research Cardiovascular, Wuppertal, GermanyBayer PLC, Data science and analytics, Reading, United KingdomBayer AG, Medical Affairs & Pharmacovigilance- Pharmaceuticals, Berlin, GermanyUniversity of Chicago Medicine, Department of Medicine, Chicago, United Stateshttp://www.sciencedirect.com/science/article/pii/S2468024921010135
spellingShingle R. Agarwal
A. Joseph
P. Rossing
B. Pitt
S. Anker D
G. Filippatos
L. Ruilope M
P. Kolkhof
C. Scott
R. Lawatscheck
G. Bakris L
POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
Kidney International Reports
title POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
title_full POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
title_fullStr POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
title_full_unstemmed POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
title_short POS-829 Incidence and predictors of hyperkalaemia in patients with CKD and T2D in the FIDELIO-DKD trial
title_sort pos 829 incidence and predictors of hyperkalaemia in patients with ckd and t2d in the fidelio dkd trial
url http://www.sciencedirect.com/science/article/pii/S2468024921010135
work_keys_str_mv AT ragarwal pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT ajoseph pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT prossing pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT bpitt pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT sankerd pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT gfilippatos pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT lruilopem pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT pkolkhof pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT cscott pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT rlawatscheck pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial
AT gbakrisl pos829incidenceandpredictorsofhyperkalaemiainpatientswithckdandt2dinthefideliodkdtrial